NCM
BDSX icon

Nantahala Capital Management’s Biodesix BDSX Stock Holding History

Nantahala Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,245
Closed -$24K – 155
2025
Q2 		$24K Buy
+4,245
New +$34.3K ﹤0.01% 156

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nantahala Capital Management's BDSX Position: Q3 2025 in Review

Nantahala Capital Management sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 4,245 shares — an estimated $24K sold.

Nantahala Capital Management first reported a position in BDSX in Q2 2025 and held it in 1 quarter. The position peaked at $24K in Q2 2025. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Nantahala Capital Management reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 4,245 Biodesix shares in Q3 2025, an estimated $24K.
  • Nantahala Capital Management first reported a position in Biodesix in Q2 2025 and held it in 1 quarter.
  • Nantahala Capital Management's Biodesix position peaked at $24K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Nantahala Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.